Literature DB >> 31087027

Management of Preexisting Diabetes in Pregnancy: A Review.

Anastasia-Stefania Alexopoulos1, Rachel Blair2, Anne L Peters3.   

Abstract

Importance: The presence of preexisting type 1 or type 2 diabetes in pregnancy increases the risk of adverse maternal and neonatal outcomes, such as preeclampsia, cesarean delivery, preterm delivery, macrosomia, and congenital defects. Approximately 0.9% of the 4 million births in the United States annually are complicated by preexisting diabetes. Observations: Women with diabetes have increased risk for adverse maternal and neonatal outcomes, and similar risks are present with type 1 and type 2 diabetes. Both forms of diabetes require similar intensity of diabetes care. Preconception planning is very important to avoid unintended pregnancies and to minimize risk of congenital defects. Hemoglobin A1c goals are less than 6.5% at conception and less than 6.0% during pregnancy. It is also critical to screen for and manage comorbid illnesses, such as retinopathy and nephropathy. Medications known to be unsafe in pregnancy, such as angiotensin-converting enzyme inhibitors and statins, should be discontinued. Women with obesity should be screened for obstructive sleep apnea, which is often undiagnosed and can result in poor outcomes. Blood pressure goals must be considered carefully because lower treatment thresholds may be required for women with nephropathy. During pregnancy, continuous glucose monitoring can improve glycemic control and neonatal outcomes in women with type 1 diabetes. Insulin is first-line therapy for all women with preexisting diabetes; injections and insulin pump therapy are both effective approaches. Rates of severe hypoglycemia are increased during pregnancy; therefore, glucagon should be available to the patient and close contacts should be trained in its use. Low-dose aspirin is recommended soon after 12 weeks' gestation to minimize the risk of preeclampsia. The importance of discussing long-acting reversible contraception before and after pregnancy, to allow for appropriate preconception planning, cannot be overstated. Conclusions and Relevance: Preexisting diabetes in pregnancy is complex and is associated with significant maternal and neonatal risk. Optimization of glycemic control, medication regimens, and careful attention to comorbid conditions can help mitigate these risks and ensure quality diabetes care before, during, and after pregnancy.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31087027      PMCID: PMC6657017          DOI: 10.1001/jama.2019.4981

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  23 in total

1.  Two Subsequent Pregnancies in a Woman With Type 1 Diabetes: Artificial Pancreas Was a Gamechanger.

Authors:  Ingrid Schütz-Fuhrmann; Anna K Schütz; Marlies Eichner; Julia K Mader
Journal:  J Diabetes Sci Technol       Date:  2020-02-14

Review 2.  The Use of Non-insulin Agents in Gestational Diabetes: Clinical Considerations in Tailoring Therapy.

Authors:  Rachel A Blair; Emily A Rosenberg; Nadine E Palermo
Journal:  Curr Diab Rep       Date:  2019-12-06       Impact factor: 4.810

3.  Recurrent gestational diabetes : Breaking the transgenerational cycle with lifestyle modification.

Authors:  Thomas Liney; Nishel M Shah; Natasha Singh
Journal:  Wien Klin Wochenschr       Date:  2022-02-11       Impact factor: 1.704

4.  Documented contraceptive use after delivery in women with pre-gestational and gestational diabetes in Thailand: a single center study.

Authors:  Raksina Winaitammakul; Preeyaporn Jirakittidul; Nichamon Pingkul
Journal:  Diabetol Int       Date:  2022-05-26

5.  Maternal Hyperglycemia Induces Changes in Gene Expression and Morphology in Mouse Placentas.

Authors:  Molly Eckmann; Quanhu Sheng; Scott Baldwin H; Rolanda L Lister
Journal:  Gynecol Reprod Health       Date:  2021

Review 6.  Exercise in Pregnant Women with Diabetes.

Authors:  Tricia M Peters; Anne-Sophie Brazeau
Journal:  Curr Diab Rep       Date:  2019-08-06       Impact factor: 4.810

Review 7.  [Treatment of diabetes mellitus in perioperative medicine-an update].

Authors:  B Rupprecht; A Stöckl; S Stöckl; C Dietrich
Journal:  Anaesthesist       Date:  2020-11-03       Impact factor: 1.041

8.  Maternal Chronic Conditions and Risk of Cerebral Palsy in Offspring: A National Cohort Study.

Authors:  Marianne S Strøm; Mette C Tollånes; Allen J Wilcox; Rolv Terje Lie; Ingeborg Forthun; Dag Moster
Journal:  Pediatrics       Date:  2021-03       Impact factor: 7.124

9.  Long-term functional alterations following prenatal GLP-1R activation.

Authors:  Devon L Graham; Haley S Madkour; Brenda L Noble; Chris Schatschneider; Gregg D Stanwood
Journal:  Neurotoxicol Teratol       Date:  2021-04-20       Impact factor: 4.071

10.  Commercialized Hybrid Closed-Loop System (Minimed Medtronic 670G) Results During Pregnancy.

Authors:  Jesús Moreno-Fernández; José Alberto García-Seco
Journal:  AACE Clin Case Rep       Date:  2021-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.